| Primary |
| Asthma |
28.8% |
| Chronic Obstructive Pulmonary Disease |
19.2% |
| Dyspnoea |
9.6% |
| Torsade De Pointes |
9.6% |
| Dyspepsia |
3.8% |
| Epilepsy |
3.8% |
| Infection |
3.8% |
| Tocolysis |
3.8% |
| Blood Cholesterol Increased |
1.9% |
| Bronchitis |
1.9% |
| Cough |
1.9% |
| Depression |
1.9% |
| Drug Exposure During Pregnancy |
1.9% |
| Hypersensitivity |
1.9% |
| Hypothyroidism |
1.9% |
| Respiratory Tract Infection |
1.9% |
| Wheezing |
1.9% |
|
| Drug Hypersensitivity |
16.1% |
| Asthma |
9.7% |
| Palpitations |
9.7% |
| Infection |
6.5% |
| Product Quality Issue |
6.5% |
| Uterine Contractions During Pregnancy |
6.5% |
| Bronchospasm |
3.2% |
| Carbon Monoxide Poisoning |
3.2% |
| Death |
3.2% |
| Dyspnoea |
3.2% |
| Heart Disease Congenital |
3.2% |
| Hyperhidrosis |
3.2% |
| Hypoaesthesia Oral |
3.2% |
| Hypotension |
3.2% |
| Nasopharyngitis |
3.2% |
| Pneumonia |
3.2% |
| Polyp |
3.2% |
| Rash Maculo-papular |
3.2% |
| Sinus Arrest |
3.2% |
| Unevaluable Event |
3.2% |
|
| Secondary |
| Lower Respiratory Tract Infection |
25.5% |
| Dyspnoea |
17.0% |
| Asthma |
14.9% |
| Pain |
12.8% |
| Chronic Obstructive Pulmonary Disease |
6.4% |
| Pulmonary Embolism |
6.4% |
| Bradycardia |
4.3% |
| Bronchitis |
4.3% |
| Shock |
4.3% |
| Wheezing |
4.3% |
|
| Visual Impairment |
33.3% |
| Drug Hypersensitivity |
20.0% |
| Dermatitis Allergic |
13.3% |
| Wheezing |
13.3% |
| Blister |
6.7% |
| Device Failure |
6.7% |
| Subarachnoid Haemorrhage |
6.7% |
|
| Concomitant |
| Pain |
17.0% |
| Asthma |
13.8% |
| Product Used For Unknown Indication |
9.5% |
| Osteoporosis |
7.4% |
| Chronic Obstructive Pulmonary Disease |
6.4% |
| Depression |
4.5% |
| Drug Use For Unknown Indication |
3.7% |
| Anxiety |
3.4% |
| Cough |
3.4% |
| Bronchial Hyperreactivity |
3.2% |
| Wheezing |
3.2% |
| Hypothyroidism |
2.9% |
| Osteopenia |
2.9% |
| Anaemia |
2.7% |
| Bone Disorder |
2.7% |
| Bone Pain |
2.7% |
| Breast Cancer |
2.7% |
| Chest Pain |
2.7% |
| Gastrointestinal Haemorrhage |
2.7% |
| Gout |
2.7% |
|
| Somnolence |
8.2% |
| White Blood Cell Count Decreased |
8.2% |
| Dyspnoea |
6.8% |
| Weight Decreased |
6.8% |
| Drug Exposure During Pregnancy |
5.5% |
| Heart Valve Calcification |
5.5% |
| Palpitations |
5.5% |
| Radiotherapy |
5.5% |
| Syncope |
5.5% |
| Tremor |
5.5% |
| Drug Ineffective |
4.1% |
| Myocardial Infarction |
4.1% |
| Pain |
4.1% |
| Pericardial Effusion |
4.1% |
| Renal Failure |
4.1% |
| Urinary Retention |
4.1% |
| Vomiting |
4.1% |
| Anxiety |
2.7% |
| Dry Mouth |
2.7% |
| Hyperparathyroidism |
2.7% |
|
